Effectiveness of a new bioequivalent formulation of oseltamivir (Enfluvir (R)) on 2010-2011 seasonal influenza viruses: an open phase IV study

CEYHAN, MEHMET; KARADAĞ ÖNCEL, EDA; Badur, Selim; Ciblak, Meral; Alhan, Emre; Celik, Umit; Kurugol, Zafer; SAZ, EYLEM; ÖZSÜREKCİ, YASEMİN; ÇELİK, MELDA; Parlakay, Aslinur

doi:10.1016/j.ijid.2011.12.008

Effectiveness of a new bioequivalent formulation of oseltamivir (Enfluvir (R)) on 2010-2011 seasonal influenza viruses: an open phase IV study

Copy For Citation

CEYHAN M., KARADAĞ ÖNCEL E., Badur S., Ciblak M. A., Alhan E., Celik U. S., ...More

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, vol.16, no.4, 2012 (SCI-Expanded)

Publication Type: Article / Article
Volume: 16 Issue: 4
Publication Date: 2012
Doi Number: 10.1016/j.ijid.2011.12.008
Journal Name: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Keywords: Influenza, Children, Symptom duration, Oseltamivir, CHILDREN, BURDEN, HOSPITALIZATION, INFECTION, COMPLICATIONS, EPIDEMIOLOGY, OUTCOMES, THERAPY, ILLNESS, DISEASE
Hacettepe University Affiliated: Yes

Abstract

Objective: The aim of this multicenter prospective study was to evaluate the efficacy of a new bioequivalent formulation of oseltamivir for the treatment of influenza A, influenza B, and H1N1 during the 2010-2011 influenza season.